China Resources Double-Crane Subsidiary Receives Drug Registration Certificate for Acetazolamide Extended-Release Capsules

Jiemian··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

China Resources Double-Crane's controlled subsidiary Zhongshuai Pharmaceutical has received a drug registration certificate from the National Medical Products Administration for acetazolamide extended-release capsules. The drug has a strength of 0.5 grams, is registered as a Category 3 chemical drug, and is deemed to have passed the consistency evaluation. The announcement states that the drug is used to prevent or improve symptoms of acute mountain sickness.

Impact on assets 2

Others▲

Off-coverage companies 1

中帅医药i
Private▲ PositiveRegulationrelevance

Controlled subsidiary Zhongshuai Pharmaceutical received the drug registration certificate.